LIFE-Moms: effects of multicomponent lifestyle randomized control trial on physical activity during pregnancy in women with overweight and obesity
- PMID: 41029405
- PMCID: PMC12486678
- DOI: 10.1186/s12966-025-01805-9
LIFE-Moms: effects of multicomponent lifestyle randomized control trial on physical activity during pregnancy in women with overweight and obesity
Abstract
Background: This report details the effect of LIFE-Mom's multicomponent lifestyle interventions on physical activity (PA) and inactivity time across pregnancy (2nd and 3rd trimesters) and their effect on gestational weight gain (GWG) and maternal/neonatal outcomes, a pre-specified secondary analysis.
Methods: Pregnant people with BMI ≥ 25 kg/m2 were randomized to lifestyle interventions with dietary and PA counseling or standard care. PA and inactivity time measured by accelerometry and metabolic and inflammatory biomarkers measured in fasting blood are reported in 522 pregnant people at baseline and end of pregnancy. Generalized linear models with and without covariates were used to evaluate group differences (intervention vs. control) and, separately, time differences (total sample with both groups combined).
Results: Although there were statistically significant differences in vigorous activity between the intervention and control group (p = .024), there were no clinically meaningful differences in PA. In the combined sample, moderate to vigorous PA (MVPA) significantly decreased across pregnancy (mean ± SD: 72.9 ± 29.1 min/day vs 63.9 ± 28.1 min/day; p < 0.0001), and inactivity time increased [617.5 min/day (573.5, 659.6) vs 630.4 min/day (56.7, 679.9); p < 0.0001]. Increased inactivity time was associated with a less favorable maternal milieu (biomarker Z-scores) for pro-inflammatory (0.2 ± 0.1; p = 0.003) and cardiometabolic markers (0.1 ± 0.07; p = 0.030).
Conclusions: Physical activity declined over the course of pregnancy, though the intervention group experienced a smaller reduction in activity levels. Our results linked increased inactivity time to maternal metabolic dysregulation and inflammation. Further research is needed to determine if intensive interventions reducing inactivity can improve maternal health and weight outcomes in pregnant people with overweight and obesity.
Trial registration: NCT01545934, NCT01616147, NCT01771133, NCT01631747, NCT01768793, NCT01610752, and NCT01812694.
Keywords: Clinical trials; Gestational weight gain; Maternal health outcomes; Moderate to vigorous physical activity; Neonatal health outcomes.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Institutional review boards for each site and the LIFE-Moms Data Safety Monitoring Board approved and monitored the studies and all studies were performed in accordance with the Declaration of Helsinki. All study participants provided written and informed consent prior to participation. Consent for publication: This manuscript does not contain any details, images, or videos related to an induvial person. Competing interests: The authors declare no competing interests.
Figures
References
-
- Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41. - PubMed
-
- Song C, Lyu Y, Li C, Liu P, Li J, Ma RC, et al. Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women. Obes Rev. 2018;19(3):421–9. - PubMed
-
- Marchi J, Berg M, Dencker A, Olander EK, Begley C. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev. 2015;16(8):621–38. - PubMed
-
- Force USPST, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Behavioral counseling interventions for healthy weight and weight gain in pregnancy: US preventive services task force recommendation statement. JAMA. 2021;325(20):2087–93. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- T32DK064584/National Institute of Diabetes and Digestive And Kidney Diseases of the National Institutes of Health
- P30 DK026687, P30 DK072476, P30 DK56341/NIDDK Nutrition Obesity Research Centers
- U01 DK094466/DK/NIDDK NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- U01 HL114377/HL/NHLBI NIH HHS/United States
- U01 DK094416/DK/NIDDK NIH HHS/United States
- U54 GM104940, U54 MD007587, UL1 RR024992/National Center for Advancing Translational Sciences Clinical and Translational Science Awards
- U01 DK094418, U01 DK094463, U01 DK094416, 5U01 DK094466/The National Institute of Diabetes and Digestive and Kidney Diseases
- U01 DK094463/DK/NIDDK NIH HHS/United States
- U01 HD072834/HD/NICHD NIH HHS/United States
- P30 DK026687/DK/NIDDK NIH HHS/United States
- U01 HL114344/HL/NHLBI NIH HHS/United States
- U01 HL114344, U01 HL114377/The National Heart, Lung, and Blood Institute
- U54 MD007587/MD/NIMHD NIH HHS/United States
- P30 DK072476/DK/NIDDK NIH HHS/United States
- P30 DK056341/DK/NIDDK NIH HHS/United States
- T32 DK064584/DK/NIDDK NIH HHS/United States
- U54 GM104940/GM/NIGMS NIH HHS/United States
- U01 DK094418/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
